Literature DB >> 20738943

Severe cardiac conduction disturbances and pacemaker implantation in patients with hypertrophic cardiomyopathy.

Roberto Barriales-Villa1, Raúl Centurión-Inda, Xusto Fernández-Fernández, Martín F Ortiz, Luisa Pérez-Alvarez, Isabel Rodríguez García, Manuel Hermida-Prieto, Lorenzo Monserrat.   

Abstract

The aims of this study were to determine the prevalence of severe cardiac conduction disturbances in a cohort of 451 patients with hypertrophic cardiomyopathy and to describe the characteristics of, and outcomes in, those who required a permanent pacemaker. A pacemaker was implanted in 48 patients (11%): 20 had sinus node dysfunction and 28 had an atrioventricular conduction disturbance. Primary bradyarrhythmia (which was not related to iatrogenic atrioventricular block or therapeutic ablation of the atrioventricular node) was the reason for permanent pacemaker implantation in 36 patients (8%). In 18% of cases, at least one other family member had a permanent pacemaker. In this patient series, a high prevalence of severe cardiac conduction disturbance leading to permanent pacemaker implantation was observed. Severe cardiac conduction disturbance in hypertrophic cardiomyopathy may also have a familial component.

Entities:  

Mesh:

Year:  2010        PMID: 20738943     DOI: 10.1016/s1885-5857(10)70192-4

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  5 in total

Review 1.  The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system.

Authors:  Patrick Fitzgerald; Fred Kusumoto
Journal:  J Interv Card Electrophysiol       Date:  2018-08-10       Impact factor: 1.900

Review 2.  A primer on arrhythmias in patients with hypertrophic cardiomyopathy.

Authors:  Katy E Bockstall; Mark S Link
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

3.  Future bradyarrhythmia in patients with hypertrophic cardiomyopathy.

Authors:  Kosuke Nakasuka; Shuichi Kitada; Yu Kawada; Marina Kato; Shohei Kikuchi; Yoshihiro Seo; Nobuyuki Ohte
Journal:  Int J Cardiol Heart Vasc       Date:  2021-02-26

4.  Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA).

Authors:  Oliver P Guttmann; Menelaos Pavlou; Constantinos O'Mahony; Lorenzo Monserrat; Aristides Anastasakis; Claudio Rapezzi; Elena Biagini; Juan Ramon Gimeno; Giuseppe Limongelli; Pablo Garcia-Pavia; William J McKenna; Rumana Z Omar; Perry M Elliott
Journal:  Eur J Heart Fail       Date:  2015-07-16       Impact factor: 15.534

5.  Potential digenic inheritance of familial hypertrophic cardiomyopathy identified by whole-exome sequencing.

Authors:  Ming-Bao Ren; Xiao-Rui Chai; Lin Li; Xin Wang; Chenghong Yin
Journal:  Mol Genet Genomic Med       Date:  2020-01-20       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.